Immunovant Inc (IMVT)

Aug 12, 2025

JP Morgan Lowers Price Target for Immunovant to $37, Maintains Overweight Rating - AInvest

Aug 12, 2025

Aug 12, 2025

IMVT: Analyst Jason Gerberry Lowers Price Target to $30, Maintains 'Buy' Rating - AInvest

Aug 12, 2025

Aug 12, 2025

Immunovant's Q1 Loss Narrower Than Expected, Pipeline In Focus - Barchart.com

Aug 12, 2025

Aug 12, 2025

Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus - Yahoo Finance

Aug 12, 2025

Aug 12, 2025

Chart Patterns Forming a Bullish Setup in Immunovant Inc.Reliable Investment Entry Signals Confirmed by Charts - 선데이타임즈

Aug 12, 2025

Aug 12, 2025

What makes Immunovant Inc. stock price move sharplyWealth Tripler Trade List - newsyoung.net

Aug 12, 2025

Aug 12, 2025

Immunovant Reports Progress and Financial Results - TipRanks

Aug 12, 2025

Aug 11, 2025

Immunovant Posts 34% R&D Jump in Q1 - AOL.com

Aug 11, 2025

Aug 11, 2025

Immunovant Spends More To Move Key Drug Trials Forward - Finimize

Aug 11, 2025

Aug 11, 2025

Immunovant Pours More Into Trials And Investors Aren’t Flinching - Finimize

Aug 11, 2025

Aug 11, 2025

Stifel lowers Immunovant stock price target to $50 from $61, maintains Buy - Investing.com Canada

Aug 11, 2025

Aug 11, 2025

Assessing Immunovant's Strategic Expansion and Financial Viability Amid Widening Losses - AInvest

Aug 11, 2025

Aug 11, 2025

Immunovant's Fiscal Q1 Net Loss Widens - MarketScreener

Aug 11, 2025

Aug 11, 2025

Immunovant Posts 34% R&D Jump in Q1 - The Motley Fool

Aug 11, 2025

Aug 11, 2025

Earnings Flash (IMVT) Immunovant Posts Fiscal Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.68 Loss - MarketScreener

Aug 11, 2025

Aug 11, 2025

Immunology company Immunovant's Q1 net loss widens to $120.6 mln - MarketScreener

Aug 11, 2025

Aug 11, 2025

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025 - The Manila Times

Aug 11, 2025

Aug 11, 2025

Immunovant Launches New Clinical Trials, Reports $599M Cash Position | IMVT Stock News - Stock Titan

Aug 11, 2025

Aug 10, 2025

Candlestick Reversal Detected on Immunovant Inc.’s ChartReal Time Alerts Based on AI Prediction Triggered - metal.it

Aug 10, 2025

Aug 04, 2025

Is Immunovant Inc. a growth stock or a value stockStrong return on investment - Jammu Links News

Aug 04, 2025

Aug 03, 2025

How does Immunovant Inc. compare to its industry peersAchieve rapid portfolio appreciation today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about Immunovant Inc.Massive wealth growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Immunovant Inc. a good long term investmentFastest-growing stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Immunovant Inc. stock in 2025Sky-high return potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Immunovant Inc. stock expected to show significant growthTriple-digit growth rates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is Immunovant Inc. stock compared to the marketUnmatched market gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Immunovant Inc. stock priceCapitalize on market opportunities with confidence - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Immunovant Inc. stockOutperformance with explosive growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Immunovant Inc. stockFree Stock Movement Tracking - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Immunovant Inc. stock higher in 2025Breakthrough wealth creation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Immunovant Inc. stock overvalued or undervaluedBuild a portfolio that outperforms the market - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Immunovant Inc. in the next 12 monthsOutstanding growth strategies - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How does Immunovant Inc. generate profit in a changing economyFree Capital Growth Strategies - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What analysts say about Immunovant Inc. stockCapitalize on market momentum for big wins - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How many analysts rate Immunovant Inc. as a “Buy”Get daily updates on top-performing stocks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Why is Immunovant Inc. stock attracting strong analyst attentionMaximize gains with expert trading strategies - Jammu Links News

Aug 02, 2025

Aug 01, 2025

LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN

Aug 01, 2025

Jul 29, 2025

Immunovant appoints Eric Venker as CEO with new compensation agreement By Investing.com - Investing.com Canada

Jul 29, 2025

Jul 29, 2025

Immunovant Appoints Eric Venker as New CEO - TipRanks

Jul 29, 2025

Jul 29, 2025

Momentum Screeners Rank Immunovant Inc. in Top 5 TodayReversal Alert Based on RSI Indicator Confirmed - metal.it

Jul 29, 2025

Jul 28, 2025

Immunovant Inc. Hits Oversold Level on RSI IndicatorProfit Focused Stock Screener Results Released - metal.it

Jul 28, 2025

Jul 28, 2025

Immunovant Inc. stock volume spike explainedFree Fast Return Equity Trade Forecast - Newser

Jul 28, 2025

Jul 28, 2025

Immunovant Inc. stock daily chart insightsFree Risk Controlled Short Term Trade Plans - Newser

Jul 28, 2025

Jul 28, 2025

Can momentum traders help lift Immunovant Inc.Chart Driven Entry Timing for Swing Trades - Newser

Jul 28, 2025

Jul 27, 2025

Immunovant Inc. Company Revenue and Profit Trends: A Deep DiveFree Real-Time Stock Data - metal.it

Jul 27, 2025